PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel TSPO Radioligand
Condition(s):DementiaLast Updated:January 29, 2024Terminated
Hide Studies Not Open or Pending
Condition(s):DementiaLast Updated:January 29, 2024Terminated
Condition(s):DementiaLast Updated:April 28, 2010Completed
Condition(s):Parkinson Disease; Parkinsonism; Lewy Body Disease; Supranuclear Palsy, Progressive; Parkinsonism Vascular; Multiple System Atrophy; Corticobasal Degeneration; Alzheimer Disease; Frontotemporal Dementia; Primary Progressive Aphasia; Vascular DementiaLast Updated:May 14, 2021Completed
Condition(s):Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Primary Lateral Sclerosis; Hereditary Spastic Paraplegia; Progressive Muscular Atrophy; Multisystem ProteinopathyLast Updated:March 19, 2024Enrolling by invitation
Condition(s):GM2 Gangliosidosis; Niemann-Pick Disease, Type CLast Updated:February 26, 2024Active, not recruiting
Condition(s):Nonfluent Aphasia, Progressive; Primary Progressive Nonfluent Aphasia; Primary Progressive Non Fluent Aphasia; Progressive Supranuclear Palsy; Corticobasal Degeneration; Behavioral Variant of Frontotemporal DementiaLast Updated:August 19, 2022Withdrawn
Condition(s):Alzheimer’s Disease; Mild Cognitive Impairment; Frontotemporal DementiaLast Updated:January 14, 2016Withdrawn
Condition(s):Progranulin Mutation CarriersLast Updated:May 16, 2016Completed
Condition(s):DementiaLast Updated:March 12, 2024Recruiting
Condition(s):Frontotemporal Lobar Degeneration; Amyotrophic Lateral SclerosisLast Updated:January 20, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.